Akebia Therapeutics, Inc. (AKBA) Ownership

$1.87

south_east
-$0.05 (-2.6%)
Day's range
$1.86
Day's range
$1.93

Akebia Therapeutics, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
BLACKROCK FUNDING, INC. /DE 02/07/2025 15.10 M $28.69 M   -0.66% 7.18%
VANGUARD GROUP INC 02/11/2025 10.88 M $20.68 M   8.08% 5.17%
STATE STREET CORP 02/14/2025 6.30 M $11.98 M   83.78% 3.00%
ALERCE INVESTMENT MANAGEMENT, L.P. 02/14/2025 5.75 M $10.92 M   0.00% 2.73%
GEODE CAPITAL MANAGEMENT, LLC 02/12/2025 4.80 M $9.11 M   0.85% 2.28%
RENAISSANCE TECHNOLOGIES LLC 02/13/2025 3.82 M $7.26 M   2.84% 1.82%
QUBE RESEARCH & TECHNOLOGIES LTD 02/14/2025 1.19 M $2.26 M   -10.00% 0.57%
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. 02/10/2025 1.03 M $1.95 M   -1.89% 0.49%
GOLDMAN SACHS GROUP INC 02/11/2025 1.00 M $1.90 M   106.52% 0.48%
FEDERATED HERMES, INC. 02/13/2025 914,003 $1.74 M   5.30% 0.43%
FMR LLC 02/13/2025 747,006 $1.42 M   9.53% 0.36%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 02/06/2025 586,710 $1.11 M   3.17% 0.28%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 02/14/2025 586,097 $1.11 M   256.14% 0.28%
WELLINGTON MANAGEMENT GROUP LLP 02/12/2025 502,127 $954,042   24.07% 0.24%
BANK OF NEW YORK MELLON CORP 02/04/2025 497,547 $945,340   5.93% 0.24%
JPMORGAN CHASE & CO 02/12/2025 456,294 $866,959   363.03% 0.22%
NUVEEN ASSET MANAGEMENT, LLC 02/14/2025 380,535 $723,016   0.00% 0.18%
BARCLAYS PLC 02/13/2025 375,495 $713,000   37.50% 0.18%
UBS GROUP AG 02/14/2025 351,091 $667,073   128.48% 0.17%
BALYASNY ASSET MANAGEMENT L.P. 02/14/2025 274,452 $521,459   100.00% 0.13%
RHUMBLINE ADVISERS 01/30/2025 265,389 $504,233   9.27% 0.13%
CITIGROUP INC 02/12/2025 236,786 $449,894   56.39% 0.11%
EXOME ASSET MANAGEMENT LLC 02/14/2025 205,956 $391,316   100.00% 0.10%
JANE STREET GROUP, LLC 02/14/2025 202,275 $384,322   63.48% 0.10%
SAPIENT CAPITAL LLC 01/29/2025 200,000 $380,000   0.00% 0.10%
DEUTSCHE BANK AG\ 02/14/2025 181,048 $343,991   64.02% 0.09%
RAFFERTY ASSET MANAGEMENT, LLC 02/14/2025 179,752 $341,529   100.00% 0.09%
MILLENNIUM MANAGEMENT LLC 02/14/2025 169,647 $322,329   737.97% 0.08%
FRANKLIN RESOURCES INC 02/12/2025 167,184 $317,650   0.00% 0.08%
CREATIVE PLANNING 02/14/2025 166,303 $315,976   43.15% 0.08%
AQR CAPITAL MANAGEMENT LLC 02/14/2025 156,462 $297,278   10.93% 0.07%
TWO SIGMA ADVISERS, LP 02/14/2025 143,149 $271,983   -23.80% 0.07%
PRICE T ROWE ASSOCIATES INC /MD/ 02/14/2025 137,905 $263,000   8.89% 0.07%
MACKENZIE FINANCIAL CORP 02/20/2025 135,392 $257,245   930.38% 0.06%
SIMPLEX TRADING, LLC 02/11/2025 128,982 $245,000   100.00% 0.06%
MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. 02/14/2025 126,380 $239,766   10.72% 0.06%
DIMENSIONAL FUND ADVISORS LP 02/13/2025 125,680 $238,792   100.00% 0.06%
WELLS FARGO & COMPANY/MN 02/13/2025 122,397 $232,554   23.26% 0.06%
INVESCO LTD. 02/13/2025 120,646 $229,228   0.73% 0.06%
INTECH INVESTMENT MANAGEMENT LLC 02/11/2025 118,209 $224,597   162.30% 0.06%
RUSSELL INVESTMENTS GROUP, LTD. 02/13/2025 110,930 $210,766   -34.89% 0.05%
METLIFE INVESTMENT MANAGEMENT, LLC 02/13/2025 104,030 $197,657   52.84% 0.05%
COREBRIDGE FINANCIAL, INC. 02/11/2025 103,422 $196,502   -7.02% 0.05%
TD WATERHOUSE CANADA INC. 02/13/2025 98,618 $187,374   8.83% 0.05%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 02/14/2025 94,500 $179,550   -12.66% 0.04%
HIGHTOWER ADVISORS, LLC 02/07/2025 93,350 $177,365   0.00% 0.04%
PRELUDE CAPITAL MANAGEMENT, LLC 02/14/2025 93,151 $176,987   100.00% 0.04%
DIAMETRIC CAPITAL, LP 02/12/2025 88,115 $167,418   100.00% 0.04%
D. E. SHAW & CO., INC. 02/14/2025 82,661 $157,056   -0.36% 0.04%
ALLIANCEBERNSTEIN L.P. 02/12/2025 77,640 $147,516   0.00% 0.04%

Akebia Therapeutics, Inc. institutional Ownership - FAQ's

During the previous two years, 171 institutional investors and hedge funds held shares of Akebia Therapeutics, Inc.. The most heavily invested institutionals were:

BlackRock Funding, Inc. /DE: 15.1 M

VANGUARD GROUP INC: 10.88 M

STATE STREET CORP: 6.3 M

Alerce Investment Management, L.P.: 5.75 M

GEODE CAPITAL MANAGEMENT, LLC: 4.8 M

RENAISSANCE TECHNOLOGIES LLC: 3.82 M

32.25% of Akebia Therapeutics, Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 82.83 M shares in the last 24 months. This purchase volume represents approximately $154.89 M in transactions.